The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients

American Journal of Transplantation

Volumn 8, Issue 6, 2008, Pages 1312-1317

  Stern, M ^a   Elsasser H ^a   Honger G ^a   Steiger, J ^a   Schaub, S ^a   Hess, C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cytomegalovirus (CMV); Kidney transplantation; Natural killer cells

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS; VALGANCICLOVIR;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS INFECTION; GENE ACTIVATION; GENE FREQUENCY; GRAFT REJECTION; HLA TYPING; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROPHYLAXIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RECIPIENT; RISK FACTOR; VIRUS REACTIVATION;

ADULT; AGED; BK VIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; GENOTYPE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; POLYOMAVIRUS INFECTIONS; RECURRENCE; RISK; TUMOR VIRUS INFECTIONS;

EID: 44449165010     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02242.x     Document Type: Article

References (16)

1. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002 100 : 1935 1947.
2. Ruggeri L, Mancusi A, Capanni M et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute mye-loid leukemia: challenging its predictive value. Blood 2007 110 : 433 440.
3. Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 1977 7 : 655 663.
4. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002 169 : 5118 5129.
5. Mancusi A, Ruggeri L, McQueen K et al. Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation. Bone Marrow Transplant 2006 37 (1 Suppl S3.
6. Chen C, Busson M, Rocha V et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant 2006 38 : 437 444.
7. Cook M, Briggs D, Craddock C et al. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 2006 107 : 1230 1232.
8. Cooley S, Miller JS, Trachtenberg E et al. Activating KIR (B Haplotype) in unrelated donors improves disease-free survival after HLA-matched and mismatched allogeneic transplantation for acute myeloid leukemia: Implications for donor selection using KIR genotyping. ASH Ann Meet Abstr 2007 110 : 43.
9. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007 357 : 2601 2614.
10. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993 44 : 411 422.
11. Levey AS, Coresh J, Greene T et al. Using standard-ized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006 145 : 247 254.
12. Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997 7 : 753 763.
13. Vales-Gomez M, Reyburn HT, Erskine RA, Strominger J. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci U S A. 1998 95 : 14326 14331.
14. Stewart CA, Laugier-Anfossi F, Vely F et al. Recogni-tion of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A. 2005 102 : 13224 13229.
15. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovi-rus by activating and inhibitory NK cell receptors. Science 2002 296 : 1323 1326.
16. Kreijveld E, van der Meer A, Tijssen HJ, Hilbrands LB, Joosten I. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation. Transplantation 2007 84 : 1045 1051.